Sugi Predict

Sugi Predict / Compounds / SCHEMBL1322372

SCHEMBL1322372

SCHEMBL1322372

CC[C@H]1CN2CC[C@H]1C[C@H]2[C@H](OC)c1ccnc2ccc(OC)cc12

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 10/20 0.80
▸ KDM4E B2RXH2 6/20 0.80
▸ ALDH1A1 P00352 5/20 0.80
▸ HSD17B10 Q99714 5/20 0.80
▸ CYP3A4 P08684 4/20 0.80
▸ ADRA2A P08913 4/20 0.80
▸ SLC6A4 P31645 4/20 0.80
▸ OPRM1 P35372 4/20 0.80
▸ KCNH2 Q12809 4/20 0.80
▸ HPGD P15428 3/20 0.80
▸ TSHR P16473 2/20 0.80
▸ MEN1 O00255 2/20 0.80
▸ KMT2A Q03164 2/20 0.80
▸ SLC6A3 Q01959 2/20 0.80
▸ CHRM2 P08172 1/20 0.80
▸ SCN1A P35498 4/20 0.65
▸ SCN2A Q99250 4/20 0.65
▸ SCN3A Q9NY46 4/20 0.65
▸ LMNA P02545 1/20 0.63
▸ CALCRL Q16602 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL522675 1.00 CYP2D6 (0.80) CYP2D6KDM4EALDH1A1HSD17B10CYP3A4
SCHEMBL10066281 1.00 CYP2D6 (0.80) CYP2D6KDM4EALDH1A1HSD17B10CYP3A4
SCHEMBL10066282 1.00 CYP2D6 (0.80) CYP2D6KDM4EALDH1A1HSD17B10CYP3A4
SCHEMBL17543030 0.94 CYP2D6 (0.80) CYP2D6KDM4EALDH1A1HSD17B10CYP3A4
SCHEMBL17543192 0.94 CYP2D6 (0.80) CYP2D6KDM4EALDH1A1HSD17B10CYP3A4
SCHEMBL4489816 0.93 CYP2D6 (0.80) CYP2D6KDM4EALDH1A1HSD17B10CYP3A4
SCHEMBL9766377 0.93 CYP2D6 (0.80) CYP2D6KDM4EALDH1A1HSD17B10CYP3A4
SCHEMBL14479807 0.93 CYP2D6 (0.80) CYP2D6KDM4EALDH1A1HSD17B10CYP3A4
SCHEMBL8378300 0.93 CYP2D6 (0.80) CYP2D6KDM4EALDH1A1HSD17B10CYP3A4
SCHEMBL90648 0.93 CYP2D6 (0.80) CYP2D6KDM4EALDH1A1HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0890564-B1 Process for the preparation of a p-dihydroxyl aromatic compound RHODIA CHIMIE SA (FR) 2004-11-24 — — EP claimed
US-20210275286-A1 THREE-DIMENSIONAL PRINTING SYSTEM AND METHODS OF USE DENTSPLY SIRONA INC. (US) 2021-09-09 — — US disclosed
US-11045295-B2 Three-dimensional printing system and methods of use DENTSPLY SIRONA INC. (US) 2021-06-29 — — US disclosed
US-10780026-B2 Methods of forming dental composites and compositions for reduced shrinkage stress DENTSPLY SIRONA INC. (US) 2020-09-22 — — US disclosed
EP-3052481-B1 USE OF POLYMERIZABLE STABLE RADICALS FOR REDUCING THE SHRINKAGE STRESS OF DENTAL COMPOSITIONS DENTSPLY SIRONA INC (US) 2020-04-08 — — EP disclosed
US-10456228-B2 Method of diagnosing optical inhomogeneity of a volume scattering object and a dental tool DENTSPLY SIRONA INC. (US) 2019-10-29 — — US disclosed
US-20190224081-A1 METHODS OF FORMING DENTAL COMPOSITES AND COMPOSITIONS FOR REDUCED SHRINKAGE STRESS DENTSPLY SIRONA INC (US) 2019-07-25 — — US disclosed
US-10238476-B2 Method of attaching a dental article to the surface of the tooth DENTSPLY SIRONA INC. (US) 2019-03-26 — — US disclosed
EP-3377021-A1 ORTHODONTIC CEMENT COMPOSITIONS AND METHODS OF USE THEREOF Dentsply Sirona Inc. (US) 2018-09-26 — — EP disclosed
US-9931280-B2 Dental composite compositions for reduced shrinkage stress DENTSPLY SIRONA INC. (US) 2018-04-03 — — US disclosed
CN-1984951-A Polymer composition NOR X INDUSTRY AS (NO) 2007-06-20 — — CN disclosed
CN-1846833-A Dispersants AVECIA LTD (US) 2006-10-18 — — CN disclosed
EP-1702672-A1 Dispersants The Lubrizol Corporation (US) 2006-09-20 — — EP disclosed
WO-2005109041-A1 COMPOSITIONS FOR USE IN THE MANUFACTURE OF LENSES MEDICAL POLYMERS LIMITED (GB) 2005-11-17 — — WO disclosed
US-20030181544-A1 Dispersants LUBRIZOL CORPORATION, THE 2003-09-25 — — US disclosed
CN-1437504-A Dispersing agent AVECIA LIMITEA (GB) 2003-08-20 — — CN disclosed
EP-1276553-A2 DISPERSANTS Avecia Limited (GB) 2003-01-22 — — EP disclosed
WO-2001080987-A2 DISPERSANTS AVECIA LIMITED (GB) 2001-11-01 — — WO disclosed
US-5834176-A Silver halide photographic light-sensitive material KONICA CORPORATION (JP) 1998-11-10 — — US disclosed
EP-0752614-A2 Silver halide photographic light-sensitive material KONICA CORPORATION (JP) 1997-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10780026-B2 Methods of forming dental composites and compositions for reduced shrinkage stress SMCHD1, FHIT, ACR CYP2D6 3091/4885KDM4E 1577/4885ALDH1A1 1551/4885
US-20190224081-A1 METHODS OF FORMING DENTAL COMPOSITES AND COMPOSITIONS FOR REDUCED SHRINKAGE STRESS SMCHD1, FHIT, ACR CYP2D6 3091/4885KDM4E 1577/4885ALDH1A1 1551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.